Selected research
Market Structure
Global Leucovorin Calcium Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Leucovorin Calcium Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Leucovorin Calcium Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Leucovorin Calcium Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Leucovorin Calcium Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Leucovorin Calcium Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Leucovorin Calcium Injection include BluePoint Laboratories, Get Well Pharmaceutical, Hikma, RMPL Pharma, Sagent, Fresenius Kabi, Mylan and Teva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Leucovorin Calcium Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Leucovorin Calcium Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Leucovorin Calcium Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Leucovorin Calcium Injection market size, projected growth trends, production technologies, key applications, and end-use industries.
Leucovorin Calcium Injection Segment by Company
BluePoint Laboratories
Get Well Pharmaceutical
Hikma
RMPL Pharma
Sagent
Fresenius Kabi
Mylan
Teva
Leucovorin Calcium Injection Segment by Type
50mg/vial
100mg/vial
200mg/vial
350mg/vial
Leucovorin Calcium Injection Segment by Application
Hospital
Clinics
Recovery Center
Leucovorin Calcium Injection Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Leucovorin Calcium Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Leucovorin Calcium Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Leucovorin Calcium Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Leucovorin Calcium Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Leucovorin Calcium Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Leucovorin Calcium Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Leucovorin Calcium Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 50mg/vial
- 100mg/vial
- 200mg/vial
- 350mg/vial
Applications
- Hospital
- Clinics
- Recovery Center
Companies covered
- BluePoint Laboratories
- Get Well Pharmaceutical
- Hikma
- RMPL Pharma
- Sagent
- Fresenius Kabi
- Mylan
- Teva
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Leucovorin Calcium Injection Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Leucovorin Calcium Injection Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Leucovorin Calcium Injection Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Leucovorin Calcium Injection Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Leucovorin Calcium Injection Market Dynamics
- 2.1 Leucovorin Calcium Injection Industry Trends
- 2.2 Leucovorin Calcium Injection Industry Drivers
- 2.3 Leucovorin Calcium Injection Industry Opportunities and Challenges
- 2.4 Leucovorin Calcium Injection Industry Restraints
3 Leucovorin Calcium Injection Market by Manufacturers
- 3.1 Global Leucovorin Calcium Injection Revenue by Manufacturers (2021-2026)
- 3.2 Global Leucovorin Calcium Injection Sales by Manufacturers (2021-2026)
- 3.3 Global Leucovorin Calcium Injection Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Leucovorin Calcium Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Leucovorin Calcium Injection Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Leucovorin Calcium Injection Manufacturers, Product Type & Application
- 3.7 Global Leucovorin Calcium Injection Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Leucovorin Calcium Injection Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Leucovorin Calcium Injection Players Market Share by Revenue in 2025
- 3.8.3 2025 Leucovorin Calcium Injection Tier 1, Tier 2, and Tier 3
4 Leucovorin Calcium Injection Market by Type
- 4.1 Leucovorin Calcium Injection Type Introduction
- 4.1.1 50mg/vial
- 4.1.2 100mg/vial
- 4.1.3 200mg/vial
- 4.1.4 350mg/vial
- 4.2 Global Leucovorin Calcium Injection Sales by Type
- 4.2.1 Global Leucovorin Calcium Injection Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Leucovorin Calcium Injection Sales by Type (2021-2032)
- 4.2.3 Global Leucovorin Calcium Injection Sales Market Share by Type (2021-2032)
- 4.3 Global Leucovorin Calcium Injection Revenue by Type
- 4.3.1 Global Leucovorin Calcium Injection Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Leucovorin Calcium Injection Revenue by Type (2021-2032)
- 4.3.3 Global Leucovorin Calcium Injection Revenue Market Share by Type (2021-2032)
5 Leucovorin Calcium Injection Market by Application
- 5.1 Leucovorin Calcium Injection Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinics
- 5.1.3 Recovery Center
- 5.2 Global Leucovorin Calcium Injection Sales by Application
- 5.2.1 Global Leucovorin Calcium Injection Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Leucovorin Calcium Injection Sales by Application (2021-2032)
- 5.2.3 Global Leucovorin Calcium Injection Sales Market Share by Application (2021-2032)
- 5.3 Global Leucovorin Calcium Injection Revenue by Application
- 5.3.1 Global Leucovorin Calcium Injection Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Leucovorin Calcium Injection Revenue by Application (2021-2032)
- 5.3.3 Global Leucovorin Calcium Injection Revenue Market Share by Application (2021-2032)
6 Global Leucovorin Calcium Injection Sales by Region
- 6.1 Global Leucovorin Calcium Injection Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Leucovorin Calcium Injection Sales by Region (2021-2032)
- 6.2.1 Global Leucovorin Calcium Injection Sales by Region (2021-2026)
- 6.2.2 Global Leucovorin Calcium Injection Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Leucovorin Calcium Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Leucovorin Calcium Injection Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Leucovorin Calcium Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Leucovorin Calcium Injection Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Leucovorin Calcium Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Leucovorin Calcium Injection Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Leucovorin Calcium Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Leucovorin Calcium Injection Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Leucovorin Calcium Injection Revenue by Region
- 7.1 Global Leucovorin Calcium Injection Revenue by Region
- 7.1.1 Global Leucovorin Calcium Injection Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Leucovorin Calcium Injection Revenue by Region (2021-2026)
- 7.1.3 Global Leucovorin Calcium Injection Revenue by Region (2027-2032)
- 7.1.4 Global Leucovorin Calcium Injection Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Leucovorin Calcium Injection Revenue (2021-2032)
- 7.2.2 North America Leucovorin Calcium Injection Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Leucovorin Calcium Injection Revenue (2021-2032)
- 7.3.2 Europe Leucovorin Calcium Injection Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Leucovorin Calcium Injection Revenue (2021-2032)
- 7.4.2 Asia-Pacific Leucovorin Calcium Injection Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Leucovorin Calcium Injection Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Leucovorin Calcium Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 BluePoint Laboratories
- 8.1.1 BluePoint Laboratories Company Information
- 8.1.2 BluePoint Laboratories Business Overview
- 8.1.3 BluePoint Laboratories Leucovorin Calcium Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 BluePoint Laboratories Leucovorin Calcium Injection Product Portfolio
- 8.1.5 BluePoint Laboratories Recent Developments
- 8.2 Get Well Pharmaceutical
- 8.2.1 Get Well Pharmaceutical Company Information
- 8.2.2 Get Well Pharmaceutical Business Overview
- 8.2.3 Get Well Pharmaceutical Leucovorin Calcium Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Get Well Pharmaceutical Leucovorin Calcium Injection Product Portfolio
- 8.2.5 Get Well Pharmaceutical Recent Developments
- 8.3 Hikma
- 8.3.1 Hikma Company Information
- 8.3.2 Hikma Business Overview
- 8.3.3 Hikma Leucovorin Calcium Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Hikma Leucovorin Calcium Injection Product Portfolio
- 8.3.5 Hikma Recent Developments
- 8.4 RMPL Pharma
- 8.4.1 RMPL Pharma Company Information
- 8.4.2 RMPL Pharma Business Overview
- 8.4.3 RMPL Pharma Leucovorin Calcium Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 RMPL Pharma Leucovorin Calcium Injection Product Portfolio
- 8.4.5 RMPL Pharma Recent Developments
- 8.5 Sagent
- 8.5.1 Sagent Company Information
- 8.5.2 Sagent Business Overview
- 8.5.3 Sagent Leucovorin Calcium Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Sagent Leucovorin Calcium Injection Product Portfolio
- 8.5.5 Sagent Recent Developments
- 8.6 Fresenius Kabi
- 8.6.1 Fresenius Kabi Company Information
- 8.6.2 Fresenius Kabi Business Overview
- 8.6.3 Fresenius Kabi Leucovorin Calcium Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Fresenius Kabi Leucovorin Calcium Injection Product Portfolio
- 8.6.5 Fresenius Kabi Recent Developments
- 8.7 Mylan
- 8.7.1 Mylan Company Information
- 8.7.2 Mylan Business Overview
- 8.7.3 Mylan Leucovorin Calcium Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Mylan Leucovorin Calcium Injection Product Portfolio
- 8.7.5 Mylan Recent Developments
- 8.8 Teva
- 8.8.1 Teva Company Information
- 8.8.2 Teva Business Overview
- 8.8.3 Teva Leucovorin Calcium Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Teva Leucovorin Calcium Injection Product Portfolio
- 8.8.5 Teva Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Leucovorin Calcium Injection Value Chain Analysis
- 9.1.1 Leucovorin Calcium Injection Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Leucovorin Calcium Injection Production Mode & Process
- 9.2 Leucovorin Calcium Injection Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Leucovorin Calcium Injection Distributors
- 9.2.3 Leucovorin Calcium Injection Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst